The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:** U.S. investment firm Royalty Pharma, which is considering a $6.6-billion bid for Irish drugmaker Elan Corporation Plc, must make a firm offer by May 10 or walk away, Ireland's Takeover Panel said on Wednesday.
Elan Corporation, plc (Elan) is a neuroscience-based biotechnology company. Shares of ELN fell by 0.85% or $-0.1/share to $11.65. In the past year, the shares have traded as low as $9.37 and as high as $15.00. On average, 5782630 shares of ELN exchange hands on a given day and today's volume is recorded at 9482205.
Source
